Abstract:BackgroundIsepamicin is a weakly toxic but highly active aminoglycoside antibiotic derivative of gentamicin B. Gentamicin B is a naturally occurring minor component isolated from Micromonospora echinospora. 2ʹ-NH2-containing gentamicin C complex is a dominant compound produced by wild-type M. echinospora; by contrast, 2ʹ-OH-containing gentamicin B is produced as a minor component. However, the biosynthetic pathway of gentamicin B remains unclear. Considering that gentamicin B shares a unique C2ʹ hydroxyl group with kanamycin A, we aimed to design a new biosynthetic pathway of gentamicin B by combining twelve steps of gentamicin biosynthesis and two steps of kanamycin biosynthesis.ResultsWe blocked the biosynthetic pathway of byproducts and generated a strain overproducing JI-20A, which was used as a precursor of gentamicin B biosynthesis, by disrupting genK and genP. The amount of JI-20A produced in M. echinospora ∆K∆P reached 911 μg/ml, which was 14-fold higher than that of M. echinospora ∆P. The enzymes KanJ and KanK necessary to convert 2ʹ-NH2 into 2ʹ-OH from the kanamycin biosynthetic pathway were heterologously expressed in M. echinospora ΔKΔP to transform JI-20A into gentamicin B. The strain with kanJK under PermE* could produce 80 μg/ml of gentamicin B, which was tenfold higher than that of the wild-type strain. To enhance gentamicin B production, we employed different promoters and gene integration combinations. When a PhrdB promoter was used and kanJ and kanK were integrated in the genome through gene replacement, gentamicin B was generated as the major product with a maximum yield of 880 μg/ml.ConclusionWe constructed a new biosynthetic pathway of high-level gentamicin B production; in this pathway, most byproducts were removed. This method also provided novel insights into the biosynthesis of secondary metabolites via the combinatorial biosynthesis.

Isolation of gentamicin C compounds from culture filtrates of Micromonospora purpurea

Analysis of Amikacin Sulfate Injection by Liquid Chromatography with Pulsed Amperometric Detection

Analysis Of Gentamicin Sulfate By Liquid Chromatography With Pulsed Amperometric Detection

Separation of Macromolecular Impurities in Penicillin G Sodium by Gel Filtration Chromatography

Isolation, Purification and Structure Determination of a Novel Antifungal Compound

Evaluation of Immobilization Conditions for Enhanced Production of Gentamicin in Repeated Batch Operations by Micromonospora Echinospora

Proteomic Analysis of the Effect of CaCl2 and Sodium Citrate on Gentamicin Biosynthesis of Micromonospora echinospora SIPI-GM.01

Production of High Affinity Monoclonal Antibody and Development of Indirect Competitive Chemiluminescence Enzyme Immunoassay for Gentamicin Residue in Animal Tissues

Engineering the methyltransferase through inactivation of the genK and genL leads to a significant increase of gentamicin C1a production in an industrial strain of Micromonospora echinospora 49-92S

Methyltransferases of Gentamicin Biosynthesis.

Recent advances in the biosynthesis and production optimization of gentamicin: A critical review

Assembly of a novel biosynthetic pathway for gentamicin B production in Micromonospora echinospora

Screening Resting Cell System for Study Gentamicin Biosynthesis

Gentamicin Assay: Comparison of an Adapted EMIT Method and an RIA Method

Complete reconstitution of the diverse pathways of gentamicin B biosynthesis

Specificity and Promiscuity at the Branch Point in Gentamicin Biosynthesis

Boronic Acid-Functionalized Magnetic Covalent Organic Frameworks Based Solid-Phase Extraction Coupled with Hydrophilic Interaction Chromatography-Tandem Mass Spectrometry for the Determination of Trace Gentamicin Residues in Milk

Overproduction of Gentamicin B in Industrial Strain Micromonospora Echinospora CCTCC M 2018898 by Cloning of the Missing Genes Genr and Gens

Effect of on line ultrasonic treatment on gentamicin biosynthesis

On-Line Ultrasound Stimulates The Secretion And Production Of Gentamicin By Micromonospora Echinospora

Delineating the Biosynthesis of Gentamicin X2, the Common Precursor of the Gentamicin C Antibiotic Complex.